Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice

Journal of the American Society of Nephrology

Volumn 17, Issue 10, 2006, Pages 2664-2669

  Zhao, Hui John ^a   Wang, Suwan ^a   Cheng, Huifang ^a   Zhang, Ming Zhi ^a   Takahashi, Takamune ^a   Fogo, Agnes B ^a   Breyer, Matthew D ^a   Harris, Raymond C ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADOLESCENT; ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME DEFICIENCY; GLOMERULOSCLEROSIS; GLOMERULUS BASEMENT MEMBRANE; HYALINE DEGENERATION; HYPERGLYCEMIA; MESANGIUM; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

EID: 33749236623     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006070798     Document Type: Article

References (42)

1. Futrakul N, Butthep P, Vongthavarawat V, Futrakul P, Sirisalipoch S, Chaivatanarat T, Suwanwalaikorn S: Early detection of endothelial injury and dysfunction in conjunction with correction of hemodynamic maladjustment can effectively restore renal function in type 2 diabetic nephropathy. Clin Hemorheol Microcirc 34: 373-381, 2006
2. Jawa A, Nachimuthu S, Pendergrass M, Asnani S, Fonseca V: Impaired vascular reactivity in African-American patients with type 2 diabetes mellitus and microalbuminuria or proteinuria despite angiotensin-converting enzyme inhibitor therapy. J Clin Endocrinol Metab 91: 31-35, 2006
3. Wautier J-L, Schmidt AM: Protein glycation: A firm link to endothelial cell dysfunction. Circ Res 95: 233-238, 2004
4. Mason RM, Wahab NA: Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol 14: 1358-1373, 2003
5. Wendt TM, Tanji N, Guo J, Kislinger TR, Qu W, Lu Y, Bucciarelli LG, Rong LL, Moser B, Markowitz GS, Stein G, Bierhaus A, Liliensiek B, Arnold B, Nawroth PP, Stern DM, D'Agati VD, Schmidt AM: RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Am J Pathol 162: 1123-1137, 2003
6. White KE, Bilous RW: Structural alterations to the podocyte are related to proteinuria in type 2 diabetic patients. Nephrol Dial Transplant 19: 1437-1440, 2004
7. Predescu D, Predescu S, Shimizu J, Miyawaki-Shimizu K, Malik AB: Constitutive eNOS-derived nitric oxide is a determinant of endothelial junctional integrity. Am J Physiol Lung Cell Mol Physiol 289: L371-L381, 2005
8. Sessa WC: eNOS at a glance. J Cell Sci 117: 2427-2429, 2004
9. Noiri E, Satoh H, Taguchi J, Brodsky SV, Nakao A, Ogawa Y, Nishijima S, Yokomizo T, Tokunaga K, Fujita T: Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension 40: 535-540, 2002
10. Prabhakar SS: Role of nitric oxide in diabetic nephropathy. Semin Nephrol 24: 333-344, 2004
11. Yuen PST, Dunn SR, Miyaji T, Yasuda H, Sharma K, Star RA: A simplified method for HPLC determination of creatinine in mouse serum. Am J Physiol Renal Physiol 286: F1116-F1119, 2004
12. Qi Z, Whitt I, Mehta A, Jin J, Zhao M, Harris RC, Fogo AB, Breyer MD: Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance. Am J Physiol Renal Physiol 286: F590-F596, 2004
13. Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, Sherman PA, Sessa WC, Smithies O: Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci U S A 93: 13176-13181, 1996
14. Van Vliet BN, Chafe LL, Montant JP: Characteristics of 24 h telemetered blood pressure in eNOS-knockout and C57B1/6J control mice. J Physiol 549: 313-325, 2003
15. Cox JE, Powley TL: Development of obesity in diabetic mice pair-fed with lean siblings. J Comp Physiol Psychol 91: 347-358, 1977
16. Breyer MD, Bottinger E, Brosius FC 3rd, Coffman TM, Harris RC, Heilig CW, Sharma K: Mouse models of diabetic nephropathy. J Am Soc Nephrol 16: 27-45, 2005
17. Parving H-H, Mauer M, Ritz E: Diabetic nephropathy. In: The Kidney, 7th Ed., edited by Brenner BM, Philadelphia, WB Saunders, 2004, pp 1777-1818
18. Breyer MD, Bottinger E, Brosius FC, Coffman TM, Fogo A, Harris RC, Heilig CW, Sharma K: Diabetic nephropathy: Of mice and men. Adv Chronic Kidney Dis 12: 128-145, 2005
19. Sharma K, McCue P, Dunn SR: Diabetic kidney disease in the db/db mouse. Am J Physiol Renal Physiol 284: F1138-F1144, 2003
20. Sarafidis PA, Ruilope LM: Insulin resistance, hyperinsulinemia, and renal injury: Mechanisms and implications. Am J Nephrol 26: 232-244, 2006
21. Dobesh PP: Managing hypertension in patients with type 2 diabetes mellitus. Am J Health Syst Pharm 63: 1140-1149, 2006
22. Coleman DL, Leiter EH, Schwizer RW: Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice. Diabetes 31: 830-833, 1982
23. Forstermann U, Munzel T: Endothelial nitric oxide synthase in vascular disease: From marvel to menace. Circulation 113: 1708-1714, 2006
24. Chalupsky K, Cai H: Endothelial dihydrofolate reductase: Critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 102: 9056-9061, 2005
25. Prabhakar SS: Tetrahydrobiopterin reverses the inhibition of nitric oxide by high glucose in cultured murine mesangial cells. Am H Physiol Renal Physiol 281: F179-F188, 2001
26. Saran R, Novak JE, Desai A, Abdulhayoglu E, Warren JS, Bustami R, Handelman GJ, Barbato D, Weitzel W, D'Alecy LG, Rajagopalan S: Impact of vitamin E on plasma asymmetric dimethylarginine (ADMA) in chronic kidney disease (CKD): A pilot study. Nephrol Dial Transplant 18: 2415-2420, 2003
27. Tarnow L, Hovind P, Teerlink T, Stehouwer CD, Parving HH: Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes. Diabetes Care 27: 765-769, 2004
28. Ng DP, Krolewski AS: Molecular genetic approaches for studying the etiology of diabetic nephropathy. Curr Mol Med 5: 509-525, 2005
29. Frost D, Chitu J, Meyer M, Beischer W, Pfohl M: Endothelial nitric oxide synthase (ecNOS) 4 a/b gene polymorphism and carotid artery intima-media thickness in type-1 diabetic patients. Exp Clin Endocrinol Diabetes 111: 12-15, 2003
30. Ksiazek P, Wojewoda P, Muc K, Buraczynska M: Endothelial nitric oxide synthase gene intron 4 polymorphism in type 2 diabetes mellitus. Mol Diagn 7: 119-123, 2003
31. Zanchi A, Moczulski DK, Hanna LS, Wantman M, Warram JH, Krolewski AS: Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int 57: 405-413, 2000
32. Li C, Dong Y, Lu W: The association between polymorphism of endothelial nitric oxide synthase gene and diabetic nephropathy [in Chinese]. Zhonghua Nei Ke Za Zhi 40: 729-732, 2001
33. Neugebauer S, Baba T, Watanabe T: Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes. Diabetes 49: 500-503, 2000
34. Asakimori Y, Yorioka N, Yamamoto I, Okumoto S, Doi S, Hirai T, Taniguchi Y: Endothelial nitric oxide synthase intron 4 polymorphism influences the progression of renal disease. Nephron 89: 219-223, 2001
35. Degen B, Schmidt S, Ritz E: A polymorphism in the gene for the endothelial nitric oxide synthase and diabetic nephropathy. Nephrol Dial Transplant 16: 185, 2001
36. Freedman BI, Yu H, Anderson PJ, Roh BH, Rich SS, Bowden DW: Genetic analysis of nitric oxide and endothelin in end-stage renal disease. Nephrol Dial Transplant 15: 1794-1800, 2000
37. Lin S, Qu H, Qiu M: Allele A in intron 4 of ecNOS gene will not increase the risk of diabetic nephropathy in type 2 diabetes of Chinese population. Nephron 91: 768, 2002
38. Rippin JD, Patel A, Belyaev ND, Gill GV, Barnett AH, Bain SC: Nitric oxide synthase gene polymorphisms and diabetic nephropathy. Diabetologia 46: 426-428, 2003
39. Shimizu T, Onuma T, Kawamori R, Makita Y, Tomino Y: Endothelial nitric oxide synthase gene and the development of diabetic nephropathy. Diabetes Res Clin Pract 58: 179-185, 2002
40. Komers R, Anderson S: Paradoxes of nitric oxide in the diabetic kidney. Am J Renal Physiol 284: F1121-F1137, 2003
41. Ribeiro MO, Antunes E, de Nucci G, Lovisolo SM, Zatz R: Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension 20: 298-303, 1992
42. Fujihara CK, De Nucci G, Zatz R: Chronic nitric oxide synthase inhibition aggravates glomerular injury in rats with subtotal nephrectomy. J Am Soc Nephrol 5: 1498-1507, 1995